National Coverage Analysis (NCA)

MONOCLONAL ANTIBODIES DIRECTED AGAINST AMYLOID for the Treatment of Alzheimer’s Disease

CAG-00460N

Expand All | Collapse All

Documents

Contacts

Joseph Hutter, M.D.

David Dolan
David.Dolan@cms.hhs.gov
410-786-3365

History of Considerations

History Title ID
Original Consideration Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease CAG-00460N You are here